NEWS

Interventional Neuroradiology during the COVID-19 pandemic

Rodrigo Rivera, editor-in-chief of LINNC Online, explains how his hospital is preparing the arrival of the Covid-19 pandemic in Chile and shares a special protocol used in Spain.

Spinal epidural arteriovenous fistula embolization

LINNC Paris postponed!

Removal of a 11cm thrombus!

Intracranial Pellet Embolization

COVID-19: Update from LINNC

LINNC Americas postponed!

First US treatment of 3 patients with the FRED device

Cerus Endovascular Successfully Completes Series B Financing and Receive...

FREMONT, Calif. and OXFORD, England, Feb. 21, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has now successfully completed its Series B financing having raised a total of $19.0 million from current and new institutional investors since commencement of the round in July 2018. The company also reported that it has received approval from the U.S. Food and Drug Administration (FDA) for its first microcatheter. Commercial sales are expected to begin during the second quarter of 2020.